Provided by Tiger Fintech (Singapore) Pte. Ltd.

Zentalis Pharmaceuticals, LLC

1.41
+0.01000.71%
Volume:442.44K
Turnover:616.62K
Market Cap:101.71M
PE:-0.62
High:1.42
Open:1.41
Low:1.36
Close:1.40
52wk High:5.44
52wk Low:1.01
Shares:72.14M
Float Shares:49.92M
Volume Ratio:0.94
T/O Rate:0.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2763
EPS(LYR):-2.3331
ROE:-49.55%
ROA:-25.41%
PB:0.37
PE(LYR):-0.60

Loading ...

Guggenheim Sticks to Their Buy Rating for Zentalis Pharmaceuticals (ZNTL)

TIPRANKS
·
Mar 30

Zentalis Pharmaceuticals Price Target Maintained With a $4.00/Share by Wedbush

Dow Jones
·
Mar 28

Stifel Nicolaus Sticks to Their Buy Rating for Zentalis Pharmaceuticals (ZNTL)

TIPRANKS
·
Mar 27

Oppenheimer Remains a Buy on Zentalis Pharmaceuticals (ZNTL)

TIPRANKS
·
Mar 27

Zentalis Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 27

BRIEF-Zentalis Pharmaceuticals Inc Files For Mixed Shelf Of Up To $250 Million - SEC Filing

Reuters
·
Mar 27

Zentalis Pharmaceuticals FY24 EPS ($2.33) Up From ($4.47) YoY)

Benzinga
·
Mar 27

Press Release: Zentalis Pharmaceuticals Reports Full Year 2024 Financial Results and Operational Updates

Dow Jones
·
Mar 27

Zentalis Pharmaceuticals Inc expected to post a loss of 71 cents a share - Earnings Preview

Reuters
·
Mar 21

Zentalis Pharmaceuticals Inc expected to post a loss of 71 cents a share - Earnings Preview

Reuters
·
Mar 17

Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer

GlobeNewswire
·
Mar 15

Zentalis Pharmaceuticals Inc expected to post a loss of 71 cents a share - Earnings Preview

Reuters
·
Mar 10

Zentalis Pharmaceuticals Inc expected to post a loss of 71 cents a share - Earnings Preview

Reuters
·
Mar 05

BRIEF-Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Mar 04

Zentalis Pharmaceuticals Announces Multiple Data Presentations at Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer

GlobeNewswire
·
Mar 03

Zentalis Pharmaceuticals Inc expected to post a loss of 71 cents a share - Earnings Preview

Reuters
·
Feb 28

Zentalis Pharmaceuticals Inc expected to post a loss of 71 cents a share - Earnings Preview

Reuters
·
Feb 21

Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies’ Board of Directors at 2025 Annual Meeting

Business Wire
·
Feb 19